Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000644419 | SCV000766112 | benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001022634 | SCV001184393 | likely benign | Hereditary cancer-predisposing syndrome | 2019-06-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000644419 | SCV002039481 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001022634 | SCV002533938 | benign | Hereditary cancer-predisposing syndrome | 2021-05-10 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002499099 | SCV002807992 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-10-27 | criteria provided, single submitter | clinical testing |